Reporter Nov 13 2020

A cohort for type 2 diabetes studies

A study group of more than 600,000 patients with type 2 diabetes, identified from electronic medical records in the PCORnet national research network, could be valuable for assessing the safety of type 2 diabetes drugs.

Imaging “biomarker” for Alzheimer’s disease progression

Changes in connectivity in the brain’s white matter may be a novel neuroimaging biomarker for assessing Alzheimer’s disease progression.

Pawlikowski named interim president of Vanderbilt Psychiatric Hospital

Mary Pawlikowski, MA, MEd, Chief Operating Officer of Vanderbilt Behavioral Health, has been named interim president of the Vanderbilt Psychiatric Hospital (VPH), succeeding Jameson Norton, MBA, in the role he has held since 2016.

Eavey to step down from Otolaryngology leadership roles

Roland “Ron” Eavey, MD, SM, Guy M. Maness Professor and chair of the Department of Otolaryngology-Head and Neck Surgery, will be stepping down from his position as the department’s leader at the end of the academic year.

New therapeutic target for lung cancer

Vanderbilt researchers have identified a new molecular partner — and potential therapeutic target — in a signaling axis that drives lung cancer.

Breast cancer treatment in older women

A new study from Vanderbilt epidemiologists suggests that it’s time to reconsider clinical practice guidelines for the treatment of early-stage breast cancer in older women.

1 2